pubmed-article:1386917 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0024554 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0020731 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0042397 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0441472 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0234422 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0205099 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C1521801 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C1533157 | lld:lifeskim |
pubmed-article:1386917 | lifeskim:mentions | umls-concept:C0068619 | lld:lifeskim |
pubmed-article:1386917 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:1386917 | pubmed:dateCreated | 1992-9-17 | lld:pubmed |
pubmed-article:1386917 | pubmed:abstractText | The effects of intracerebroventricular (i.v.t.) injections of pertussis toxin (PTX) (10 micrograms/30 microliters, 48 h) were studied on the cardiovascular actions of i.v.t. administered neuropeptide Y(13-36) (NPY(13-36)) as evaluated in the awake unrestrained male rat. The vasopressor action of NPY(13-36) in the peak dose of 3000 pmol per rat was significantly inhibited by pretreatment by PTX. Pertussis toxin treatment alone significantly reduced the baroreceptor reflex elicited by L-phenylephrine. The results are compatible with the view that G-proteins mediate the central vasopressor actions of NPY(13-36) and thus probably are involved in NPY Y2-receptor transduction in cardiovascular areas of the brainstem. | lld:pubmed |
pubmed-article:1386917 | pubmed:language | eng | lld:pubmed |
pubmed-article:1386917 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:1386917 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:1386917 | pubmed:month | Jun | lld:pubmed |
pubmed-article:1386917 | pubmed:issn | 0304-3940 | lld:pubmed |
pubmed-article:1386917 | pubmed:author | pubmed-author:FuxeKK | lld:pubmed |
pubmed-article:1386917 | pubmed:author | pubmed-author:NarváezJ AJA | lld:pubmed |
pubmed-article:1386917 | pubmed:author | pubmed-author:AguirreJ AJA | lld:pubmed |
pubmed-article:1386917 | pubmed:author | pubmed-author:Van der... | lld:pubmed |
pubmed-article:1386917 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:1386917 | pubmed:day | 22 | lld:pubmed |
pubmed-article:1386917 | pubmed:volume | 140 | lld:pubmed |
pubmed-article:1386917 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:1386917 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:1386917 | pubmed:pagination | 273-6 | lld:pubmed |
pubmed-article:1386917 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:meshHeading | pubmed-meshheading:1386917-... | lld:pubmed |
pubmed-article:1386917 | pubmed:year | 1992 | lld:pubmed |
pubmed-article:1386917 | pubmed:articleTitle | Intracerebroventricularly administered pertussis toxin blocks the central vasopressor action of neuropeptide Y(13-36) in the awake unrestrained male rat. | lld:pubmed |
pubmed-article:1386917 | pubmed:affiliation | Department of Histology and Neurobiology, Karolinska Institutet, Stockholm, Sweden. | lld:pubmed |
pubmed-article:1386917 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:1386917 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1386917 | lld:pubmed |